SCHEMBL13692170

SCHEMBL13692170

CCCCN1CCN(CC(=O)OCC(=O)[C@@]2(O)CCC3C4CCC5=CC(=O)CC[C@]5(C)C4[C@@H](O)C[C@@]32C)CC1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 11/20 0.76
▸ SMN1; SMN2 Q16637 3/20 0.76
▸ MAPT P10636 2/20 0.76
▸ POLB P06746 1/20 0.76
▸ GAA P10253 1/20 0.76
▸ PGR P06401 4/20 0.70
▸ SERPINA6 P08185 2/20 0.70
▸ LMNA P02545 2/20 0.70
▸ AR P10275 2/20 0.70
▸ CHRM1 P11229 2/20 0.70
▸ CYP3A4 P08684 2/20 0.68
▸ NFKB1 P19838 2/20 0.68
▸ PMP22 Q01453 1/20 0.68
▸ TSHR P16473 1/20 0.68
▸ NR3C2 P08235 5/20 0.63
▸ NR3C1 P04150 3/20 0.63
▸ CYP2C19 P33261 2/20 0.63
▸ HSD17B10 Q99714 2/20 0.63
▸ KMT2A Q03164 2/20 0.63
▸ SHBG P04278 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13694229 0.92 HIF1A (0.67) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL2679288 0.89 HIF1A (0.95) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL80604 0.89 HIF1A (0.95) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL13692158 0.87 HIF1A (0.62) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL5084679 0.87 HIF1A (0.98) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL7137200 0.86 HIF1A (1.00) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL141851 0.86 HIF1A (1.00) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL7142712 0.86 HIF1A (1.00) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL3488312 0.86 HIF1A (1.00) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL13692220 0.86 HIF1A (0.70) HIF1ASMN1; SMN2MAPTPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221543-A1 NEW CORTICOSTEROIDS NICOX S A. (FR) 2009-09-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221543-A1 NEW CORTICOSTEROIDS CYP11B1, NR3C1, NR3C2 HIF1A 1741/4885SMN1; SMN2 4258/4885MAPT 4074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback